PATRYS Ltd

PAB · AU

0.023AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.023

Open0.024

Day Range0.023 – 0.024

52-Week Range0.019 – 0.052

Volume239.30K

Market Cap11.21M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.02

Dividend Yield0.00%

Beta1.25

50-Day Avg0.033

200-Day Avg0.0335

About

Patrys Limited, together with its subsidiaries, develops antibody technologies for the treatment of cancer and NETosis-driven inflammatory diseases. It develops PAT-DX1, a small antibody fragment derived from a humanized version of the binding domain from the original mouse deoxymab antibody 3E10; and PAT-DX3 for treating primary and secondary brain cancers, and metastases that are associated with NETosis, or in combination with DNA damaging agents, such as radiation and other chemotherapy drugs. The company was incorporated in 2006 and is based in Nedlands, Australia.

Company Details

CEODr. Samantha South GAICD, MBA, Ph.D.
Employees0
Headquarters168 Stirling Highway, Nedlands, WA, Australia, 6009, Australia
Websitehttps://patrys.com

Leadership

Dr. Samantha South GAICD, MBA, Ph.D.Chief Executive Officer
Mr. Johnathon Busing C.A.Joint Company Secretary
Mr. Kieran Witt C.A.Joint Company Secretary

Financials

Income Statement

Currency: AUD	2007-06-30	2008-06-30	2009-06-30	2010-06-30	2011-06-30	2012-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30

Currency: AUD	2007-06-30	2008-06-30	2009-06-30	2010-06-30	2011-06-30	2012-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Total Revenue	60.00K	1.11M	3.73K	4.65K	7.60K	4.85K	2.64K	759.68K	2.22M	274.97K	53.26K	520.52K	844.37K	27.50K	27.50K	27.50K	2.85M	1.39M	828.54K	8.98K
Growth (%)	-	+1753.33%	-99.66%	+24.61%	+63.28%	-36.16%	-45.52%	+28643.21%	+192.82%	-87.64%	-80.63%	+877.27%	+62.21%	-96.74%	0.00%	0.00%	+10270.57%	-51.11%	-40.57%	-98.92%
Cost of Revenue	-	-	-	-	-	-	-	0	0	-592.68K	-478.47K	0	-	-745.34K	-1.31M	-3.31M	46.99K	47.00K	-	346
Gross Profit	-	-	3.73K	4.65K	7.60K	4.85K	2.64K	759.68K	2.22M	867.65K	531.73K	520.52K	844.37K	772.84K	1.34M	3.33M	2.80M	1.39M	828.54K	8.98K
Gross Margin	-	-	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	315.54%	998.31%	100.00%	100.00%	2810.34%	4866.83%	12122.09%	98.35%	100.00%	100.00%	100.00%
Operating Expense	-	-	11.90M	10.13M	9.26M	7.95M	5.35M	8.04M	5.71M	2.59M	2.89M	3.02M	4.26M	4.27M	7.20M	14.71M	12.67M	4.93M	3.54M	3.43M
Operating Income	-	-8.67M	-11.90M	-10.12M	-9.25M	-7.95M	-5.34M	-7.28M	-3.48M	-1.72M	-2.36M	-2.50M	-3.41M	-3.49M	-5.86M	-11.37M	-9.86M	-3.54M	-2.71M	-3.42M
Operating Margin	-	-779.66%	-318619.81%	-217460.34%	-121760.34%	-163851.35%	-202146.80%	-958.42%	-156.61%	-626.26%	-4430.75%	-479.76%	-404.01%	-12705.02%	-21303.78%	-41362.58%	-345.77%	-253.85%	-327.03%	-38103.23%
EBITDA	-	-6.94M	-7.94M	-6.42M	-6.39M	-6.17M	-4.70M	-7.32M	-2.88M	-1.56M	-1.42M	-2.90M	-3.36M	-3.32M	-5.69M	-11.52M	-9.79M	-3.49M	-2.66M	-3.42M
EBITDA Margin	-	-623.68%	-212703.45%	-138050.19%	-84113.08%	-127091.40%	-177662.32%	-963.39%	-129.47%	-568.47%	-2666.95%	-558.02%	-398.29%	-12087.08%	-20682.46%	-41891.12%	-343.27%	-250.48%	-321.08%	-38103.23%
Net Income	-	-7.32M	-8.66M	-7.54M	-7.42M	-5.11M	-3.53M	-7.29M	-8.47M	-1.08M	-1.06M	-2.50M	-411.33K	-2.75M	-4.06M	-6.78M	-7.06M	-3.54M	-3.01M	-3.41M
Net Income Margin	-	-658.60%	-231923.40%	-161906.38%	-97666.40%	-105316.24%	-133526.11%	-959.49%	-380.78%	-393.06%	-1986.14%	-479.76%	-48.71%	-9994.69%	-14774.25%	-24655.87%	-247.61%	-253.85%	-363.69%	-38003.23%
R&D	785.00K	5.62M	9.10M	6.98M	6.30M	4.83M	3.30M	6.30M	4.67M	1.04M	1.27M	1.31M	1.69M	1.37M	2.86M	8.09M	7.52M	3.07M	1.75M	1.71M
R&D as % of Total Revenue	1308.33%	505.03%	243730.12%	149912.44%	82895.18%	99529.23%	124923.38%	829.06%	210.14%	379.04%	2375.71%	251.15%	199.67%	4974.50%	10406.92%	29400.83%	263.85%	220.33%	211.72%	18991.68%
Interest Expense	0	1.54K	4.06K	2.69K	222.60K	0	0	0	0	0	0	0	0	0	0	8.10K	-	-	-	-
Interest Expense % of Total Revenue	0.00%	0.14%	108.73%	57.86%	2929.35%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	29.44%	-	-	-	-

Balance Sheet

Currency: AUD	2007-06-30	2008-06-30	2009-06-30	2010-06-30	2011-06-30	2012-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30

Currency: AUD	2007-06-30	2008-06-30	2009-06-30	2010-06-30	2011-06-30	2012-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Total Assets	818.81K	23.86M	19.18M	16.31M	14.85M	13.36M	11.85M	14.81M	4.77M	4.26M	3.16M	7.97M	7.93M	5.38M	12.89M	13.97M	7.52M	4.16M	1.74M	11.10M
Total Liabilities	2.36M	882.30K	1.46M	1.07M	1.38M	916.36K	1.08M	2.38M	802.28K	620.26K	495.53K	681.77K	637.42K	498.38K	849.86K	542.83K	686.90K	691.37K	1.01M	918.55K
Total Equity	818.81K	22.98M	17.72M	15.23M	13.47M	12.45M	10.77M	12.43M	3.97M	3.64M	2.66M	7.29M	7.30M	4.88M	12.04M	13.43M	6.84M	3.47M	732.87K	10.18M
Cash	753.00K	15.23M	9.60M	6.78M	6.20M	6.19M	5.23M	8.64M	4.65M	3.22M	1.91M	4.61M	6.47M	3.98M	6.92M	7.82M	3.05M	2.24M	742.44K	3.36M
Total Debt	-	34.09K	24.93K	18.97K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Debt	-753.00K	-15.20M	-9.57M	-6.76M	-6.20M	-6.19M	-5.23M	-8.64M	-4.65M	-3.22M	-1.91M	-4.61M	-6.47M	-3.98M	-6.92M	-7.82M	-3.05M	-2.24M	-742.44K	-3.36M

Cash Flow

Currency: AUD	2007-06-30	2008-06-30	2009-06-30	2010-06-30	2011-06-30	2012-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30

Currency: AUD	2007-06-30	2008-06-30	2009-06-30	2010-06-30	2011-06-30	2012-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Operating Cash Flow	-	-7.45M	-7.26M	-7.05M	-5.11M	-3.75M	-2.63M	-5.09M	-4.11M	-1.53M	-1.28M	-2.09M	-129.19K	-2.50M	-3.88M	-8.68M	-5.78M	-1.82M	-1.77M	-2.17M
Investing Cash Flow	-	-3.38M	-2.00M	-1.33M	-864.11K	-386.74K	-208.60K	-74.59K	-137.68K	64.07K	-2.77K	-2.00M	2.00M	-4.00M	-4.00M	1.99M	1.00M	1.01M	0	-3.85K
Financing Cash Flow	6.26M	23.75M	3.07M	4.97M	5.42M	4.14M	1.69M	8.92M	6.82M	6.82M	6.82M	6.82M	1.80K	2.50M	11.05M	7.56M	6.45K	4.29K	275.96K	4.79M
Capital Expenditure	61.00K	1.50M	1.39M	1.33M	917.46K	386.74K	231.56K	74.59K	1.82K	4.90K	2.77K	4.13K	4.06K	3.89K	3.89K	2.29K	0	3.24K	2	3.85K
Free Cash Flow	-	-8.95M	-8.65M	-8.38M	-6.03M	-4.14M	-2.86M	-5.16M	-4.12M	-1.54M	-1.28M	-2.09M	-133.25K	-2.50M	-3.88M	-8.68M	-5.78M	-1.82M	-1.77M	-2.17M
FCF to OCF	-	120.10%	119.15%	118.84%	117.94%	110.30%	108.81%	101.47%	100.04%	100.32%	100.22%	100.20%	103.14%	100.00%	100.10%	100.03%	100.00%	100.18%	100.00%	100.18%

Earnings

Report Date	Feb 24, 2016	Aug 30, 2016	Feb 23, 2017	Aug 29, 2017	Feb 23, 2018	Aug 24, 2018	Feb 20, 2019	Aug 22, 2019	Feb 24, 2020	Aug 25, 2020	Feb 19, 2021	Aug 25, 2021	Feb 24, 2022	Aug 30, 2022	Feb 24, 2023	Feb 21, 2025	Sep 5, 2025
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EPS Actual	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	Pre-market	-	-

Key Statistics & Ratios

Market Cap11.21M

Enterprise Value15.27M

Trailing P/E0.00

Forward P/E0.00

Price / Sales1248.17

Price / Book18.34

EPS-0.02

Book Value0.015

Revenue (TTM)8.98K

Gross Profit (TTM)8.98K

EBITDA-3.42M

Profit Margin0.00%

Operating Margin-5896.41%

Return on Equity-68.25%

Return on Assets-35.78%

Shares Outstanding340.73M

Shares Float386.97M

Beta1.25

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Oct 13, 20251:15
Jul 31, 202531:22
Nov 3, 2021481:479
Nov 11, 2020147:146
Jan 17, 2018143:138
Nov 19, 201396:89